WS12-4 Long-term safety and efficacy of lumacaftor/ivacaftor therapy in patients aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation (F/F)
Chilvers, M., Davies, J.C., Ratjen, F., Milla, C., Owen, C.A., Tian, S., Han, Z., Wang, L.T.Volume:
18
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(19)30189-4
Date:
June, 2019
File:
PDF, 60 KB
english, 2019